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Summary
 
B cells that mediate normal, T cell–dependent, humoral immune responses must first pass
through germinal centers (GCs) within the cortex of antigenically stimulated lymph nodes. As
they move through the dark zone and then the light zone in the GC, B cells are subjected to
somatic hypermutation and switch recombination within their rearranged immunoglobulin
genes and also participate in a number of other processes that control development into mem-
ory cells or cells specialized for antibody secretion. To investigate the molecular mechanisms
that contribute to B cell development within GCs, we constructed a recombinant DNA library
enriched for cDNAs derived from human genes expressed in B cells at this site. This library was
found to contain a cDNA structurally and functionally related to genes in bacteria and yeast for
the DNA repair enzyme 8-oxoguanine DNA glycosylase. Northern blot analysis indicated that
the human gene is expressed as two alternatively spliced messenger RNAs within GC B cells at
levels greatly exceeding that found in other tissues. In situ hybridization studies revealed that
expression of this gene is most abundant within the dark zones of GCs. Both the function and
localized expression of this gene suggest that it may play a role in somatic hypermutation of im-
munoglobulin genes.
 
G
 
erminal centers (GCs)
 
1
 
 are sites of B cell development
critical to the mounting of normal humoral immune
responses (1–4). Anatomically, GCs are well-defined nodu-
lar structures that appear in the cortex of lymph nodes after
stimulation by T cell–dependent antigens. Each GC con-
tains about 10
 
4
 
–10
 
5
 
 cells, most of which are B cells, with
smaller numbers of scattered T cells, follicular dentritic cells
(DCs), and macrophages. Two zones can be distinguished
in standard histologic sections of GCs, a dark zone of more
densely packed cells located at one pole and a light zone
occupying the remaining portion of the GC. Each GC is
surrounded by a shell of homogeneously small, resting B
cells, constituting a region referred to as the mantle zone,
which is usually thickest at the point opposite the dark
zone.
A variety of events that occur within GCs are required
for the production of antibody with both high affinity for
antigen and the proper effector functions necessary for the
recognition and elimination of foreign substances in a range
of biologic contexts. Naive B cells, which probably first en-
counter antigen in the interfollicular region of the lymph
node cortex, enter the primary lymphoid follicles where
they undergo rapid proliferation driven by antigen and cy-
tokines secreted by helper T lymphocytes (5, 6). These B
cells assume an altered morphology, with larger overall di-
ameter and vesicular nuclei, and are termed centroblasts.
Clonal expansion of these cells establishes the dark zone of
the GC. During this phase of B cell development, point
mutations accumulate within the DNA of variable (V) gene
segments in rearranged immunoglobulin genes, a process
referred to as somatic hypermutation (7–13). B cells with
mutated V gene segments move out of the dark zone to an
adjacent region that becomes the light zone, where the
cells take on a morphology with a smaller cellular diameter
and irregularly shaped, denser nuclei, in which state they
are referred to as centrocytes. Within the light zone, B cells
displaying surface immunoglobulin with higher affinity for
antigen presented by follicular DCs are selected for further
expansion, whereas cells bearing immunoglobulin that fails
to bind antigen or does so with lower affinity die through a
form of apoptosis and are scavenged by macrophages (14–
16). Together, these events lead to the so-called affinity
maturation of the humoral immune response.
Other prominent events in B cell development probably
occur only after transit to the light zone. For example, ho-
mologous recombination at specific switch regions within
 
1
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the DNA of immunoglobulin heavy chain genes, a process
referred to as switch recombination, substitutes different
coding sequences for the COOH-terminal part of the heavy
chain (3, 5, 17). These sequences determine the class of an-
tibody produced by the B lymphocyte and the ability of
that antibody to fix complement, attach to mast cells, or ef-
ficiently cross through mucosal barriers. B cells that survive
selection in the light zone cease dividing but continue to ex-
perience further maturational changes, such as conversion
to long-lived memory cells or adaptation for antibody se-
cretion (18), before they finally migrate out of the GC into
surrounding areas of the lymph node, undergo further
clonal expansion, and eventually enter the general circula-
tion.
Although there has been some progress in recent years
toward understanding certain aspects of events in the GC
such as switch recombination and the determination of
secretory versus memory cell fate, relatively little is known
about the molecular mechanisms directly responsible for
other processes such as lymphocyte trafficking within GCs
and the signals controlling apoptosis of B cells producing
low affinity or autoreactive antibody (17, 19–23). In partic-
ular, insights into the mutational activities underlying so-
matic hypermutation, the only known example in biology
of a developmentally regulated and sequence-specific muta-
tion, have remained elusive despite intense interest and
considerable speculation about a host of hypothetical expla-
nations (24–32). Because of the paucity of information
available to explain the many important events that take
place within GCs, we constructed a subtractive human
cDNA library enriched for reverse transcripts representative
of genes expressed in GCs of antigenically stimulated
lymph nodes. We describe here two related cDNAs which
were isolated from this library and have structural and func-
tional features consistent with a role in DNA repair and
possibly in somatic hypermutation.
 
Materials and Methods
 
Tissues.
 
Tonsils from children 2–6 yr of age were collected
within 3 h of routine tonsillectomy at the Children’s Hospital in
Boston (Boston, MA). Fresh frozen lymph node tissues containing
small lymphocytic and mantle cell lymphoma were selected from
the archives of the Pathology Department of Brigham and
Women’s Hospital (Boston, MA). By histologic and immunohis-
tochemical evaluation, over 95% of the cells in these tissues were
estimated to be malignant. Fetal tissues were dissected from rou-
tine abortion specimens of 
 
z
 
20 wk gestational age which showed
no apparent gross abnormalities.
 
Isolation of GC B Cells from Tonsils.
 
Single cell suspensions were
prepared from tonsils by crushing fragments of tissue between the
frosted ends of two microscopic slides. The mononuclear cells
were separated by loading the suspensions on top of 15 ml of Fi-
coll-Hypaque (Pharmacia, Piscataway, NJ) and centrifuging at
1,500 rpm for 30 min at 15
 
8
 
C. Cells at the interface were col-
lected, washed in RPMI tissue culture medium (Sigma Chemical
Co., St. Louis, MO) supplemented with 10% heat-inactivated fe-
tal calf serum, and resuspended at a concentration of 10
 
7
 
 cells/ml in
fresh medium supplemented with serum. The suspensions of
mononuclear cells were placed for 1 h at 4
 
8
 
C in 100-mm tissue
culture dishes (10 ml/dish) coated with peanut agglutinin (PNA;
160 
 
m
 
g/ml in PBS; Sigma Chemical Co.) to further separate GC
B cells used for preparation of cDNA.
In later studies, magnetic beads coated with specific antibodies
were used for separations of B cells from disaggregated tonsils. T
cells were first removed by two rounds of separation using a 1:10
cell/bead ratio of beads coated with anti-CD2 antibody (Dynal,
Rochester, NY). The B cells left in suspension were then sepa-
rated into surface IgD-positive and -negative populations by add-
ing mouse anti–human IgD (1:20 dilution in PBS; Sigma Chemi-
cal Co.) plus magnetic beads coated with anti–mouse antibody
(beads/cells ratio of 10:1) to cells at a concentration of 10
 
7
 
 cells/ml.
Flow cytometric analysis of separated cells showed that GC B
cells prepared by panning were 75–80% pure (CD19
 
1
 
, CD38
 
1
 
,
and surface IgD
 
2
 
) and by magnetic beads were 
 
.
 
95%.
 
Construction of a cDNA Library Using Subtractive Hybridization.
 
Total RNA was isolated from GC B lymphocytes with Trizol so-
lution (GIBCO BRL, Gaithersburg, MD) following procedures
recommended by the manufacturer. PolyA
 
1
 
 RNA was prepared
from total RNA with Oligotex (Qiagen, Chatsworth, CA). Con-
version of RNA to double-stranded cDNA was performed start-
ing with 5 
 
m
 
g of polyA
 
1
 
 RNA from GC B cells using the Lamb-
daZAP-XR unidirectional cDNA synthesis kit (Stratagene, La
Jolla, CA). The resulting cDNAs were then ligated into the DNA
of LambdaZAP bacteriophage arms and packaged into phage par-
ticles using a Gigagold II packaging kit (Stratagene). The phage
were then used to infect 
 
Escherichia coli
 
 XL1-blue (Stratagene). To
generate a subtractive cDNA library, single-stranded DNA circles
(the “tracer”) were produced from recombinant LambdaZAP
bacteriophage by coinfection with the helper phage R408. Hy-
bridization was performed with pooled, photobiotinylated RNA
(the “driver”) isolated from two lymph nodes containing non-
Hodgkin’s lymphomas considered to be of non-GC origin. A total
of 100 
 
m
 
g of nucleic acid at a tracer/driver molar ratio of 1:100
was used in two rounds of hybridization carried out in 50 
 
m
 
l of
50% formamide, 5% dextran sulfate, 5
 
3
 
 SSC, 0.1% SDS, and 5
 
3
 
Denhardt’s solution at 42
 
8
 
C for 36 h. After hybridization, RNA–
DNA hybrids were removed by phenol–chloroform extraction.
The remaining single-stranded circles were made double-
stranded using the Klenow fragment of DNA polymerase and an
M13 reverse primer, and then transformed into competent 
 
E. coli
 
,
which were grown on agar plates to produce a pBluescript plas-
mid library of cloned cDNAs enriched for reverse transcripts of
genes expressed in GC B cells.
 
PCR.
 
With minor modifications, PCR amplifications were
performed in 1
 
3
 
 PCR buffer (Perkin-Elmer, Foster, CA) with
1.5 mM MgCl
 
2
 
, 10 pmol of each primer, 200 nM dNTPs, and
0.25 U of Taq polymerase (Perkin-Elmer) in a reaction volume
of 50 
 
m
 
l. The cycling program consisted of 30 cycles of a three-
temperature setup with denaturation at 94
 
8
 
C for 5 s, annealing at
65–55
 
8
 
C for 20 s, and extension at 72
 
8
 
C for 1 min, in a ther-
mocycler (System 9600 PCR; Perkin-Elmer).
 
Reverse Slot–blot Hybridization and Northern Blot Analysis.
 
For
reverse slot–blot hybridization, cDNAs were amplified by PCR
using T3 and T7 primers complementary to pBluescript DNA
flanking the insertion site, denatured by boiling in 1N NaOH,
and applied to Biotran nylon membranes (Schleicher & Schuell,
Keene, NH) in 2
 
3
 
 SSC with a blotter (Minifold II; Schleicher &
Schuell). The hybridization probes for this study were synthesized
by reverse transcription of polyA
 
1
 
 RNA with oligo-dT primers
and Superscript II reverse transcriptase (GIBCO BRL, Gaithers-
berg, MD). RNA from GC B cells was prepared using cells puri- 
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fied by separation with magnetic beads. Hybridization was per-
formed in 5
 
3
 
 SSC, 50% formamide, 5
 
3
 
 Denhardt’s solution,
and 0.1% SDS at 42
 
8
 
C for 16 h. After hybridization, blots were
washed twice at 65
 
8
 
C for 15 min in 0.5
 
3
 
 SSC containing 0.1%
SDS and subsequently analyzed by autoradiography against x-ray
film.
For Northern blot analysis, total RNA was fractionated by
electrophoresis through 1% agarose gels containing 1% (wt/vol)
formamide using 1
 
3
 
 MOPS running buffer and transferred after
electrophoresis onto Biotran nylon membranes. Hybridization
probes were prepared by randomly primed synthesis of DNA
from individual cDNAs with 
 
a
 
-
 
32
 
P-dCTP and the Klenow frag-
ment of DNA polymerase. Hybridization and treatment of mem-
branes was carried out as described for slot blots.
 
DNA Sequence Analysis.
 
Sequence analysis was performed by
the method of Sanger et al., and the results evaluated on a SUN
miniworkstation equipped with a Wisconsin DNA sequence
analysis package (GCG release 7). Database searches were per-
formed through the BLAST server at the National Center for
Biotechnological Information.
 
In Situ Hybridization.
 
Amplified cDNA fragments were re-
cloned in the pBluescipt plasmid vector, and after propagation in
 
Escherichia coli
 
, purified plasmid was linearized to serve as template
for probe synthesis. Digoxigenin-labeled riboprobes were synthe-
sized in the presence of digoxigenin-conjugated UTP with T3
and T7 RNA polymerase (Boehringer Mannheim, Indianapolis,
IN) following the manufacturer’s directions. Tissues were fixed in
10% buffered formalin solution, embedded in paraffin, cut into 5
 
m
 
m sections, and mounted on glass microscope slides. The
mounted sections were deparaffinized, rehydrated, and pretreated
with 0.5% acetic anhydride. Hybridization was performed in a
solution containing 50% formamide, 5
 
3
 
 SSC, 0.1% SDS, 100
 
m
 
g/ml sonicated salmon sperm DNA, 100 
 
m
 
g/ml yeast tRNA,
and 5% dextran sulfate to which probe was added at a final con-
centration of 0.025 
 
m
 
g/ml. After incubation at 42
 
8
 
C overnight in
a humidified chamber, the slides were washed twice at 55
 
8
 
C with
2
 
3
 
 SSC, 0.5
 
3
 
 SSC, and 0.1
 
3
 
 SSC. The washed slides were pre-
blocked with 2% goat serum, incubated with alkaline phos-
phatase–conjugated antidigoxigenin antibody, washed with PBS,
and reacted with substrate solution containing 5-bromo,4-chloro,
3-indolyl phosphate (Sigma Chemical Co.) for 2–16 h at room
temperature. The slides were counterstained with methyl green
and examined under a standard light transmission microscope.
 
Production of a Fusion Protein Containing Amino Acid Sequence En-
coded by the GCN6 cDNA.
 
An expression plasmid designed to
express a fused protein containing the amino acid sequences of
glutathione-S-transferase (GST) and those encoded by the cDNA
GCN6 was made by ligating a BamHI–EcoRI fragment which
includes all but the first 11 codons of the GCN6 open reading
frame into the BamHI–EcoRI sites of the plasmid GST-2TK
(Pharmacia). The MC301 mutM
 
2
 
 
 
E. coli
 
 strain (Yale Genetic
Stock Center, New Haven, CT) was transformed with this plas-
mid, induced to express the composite cDNA by addition of iso-
propylthio-
 
b
 
-galactoside (IPTG; Sigma Chemical Co.), and the
fusion protein purified by binding to and elution from glu-
tathione–Sepharose beads (Pharmacia) according to instructions
provided by the manufacturer.
 
Functional Assays of the GST-GCN6 Protein.
 
Oligonucleotides
contained 8-oxoguanine, ordered from DNAgency (Malvern, PA),
had the sequence 5
 
9
 
-CAGTCTCAAGTGTAA[8-oxo-G]TTA-
CATGCACTGGTA-3
 
9
 
 and the reverse complement of this se-
quence with C inserted opposite the 8-oxo-G. The oligonucleotide
was labeled at its 5
 
9
 
 end using T4 DNA kinase and 
 
g
 
-
 
32
 
P-dATP.
Unincorporated free nucleotides were removed by centrifugation
in a spin column, and the end-labeled oligonucleotides were an-
nealed to their complementary oligonucleotides, precipitated, and
resuspended in water. Trapping and cleavage experiments were
performed with 1 pmol of oligonucleotide, 10 ng of GST-GCN6
fusion protein in 50 mM Hepes, pH 7.0, and 1 mM EDTA in the
presence of either 50 mM freshly prepared NaBH
 
4
 
 (trapping re-
action) or NaCl (cleavage reaction). Trapping reactions were in-
cubated for 20 min at 30
 
8
 
C, after which 2
 
3
 
 SDS loading buffer
containing 1 mM dithiothreitol was added and the reactions
boiled for 10 min before loading on a 10% SDS-PAGE gel pre-
pared with standard electrophoresis buffer. Cleavage reactions
were handled similarly except for addition of 6
 
3
 
 loading buffer
before electrophoresis performed on a 12% polyacrylamide-7M
urea gel. After electrophoresis, the contents of the gels were de-
tected by autoradiography against x-ray film.
 
Results
 
Construction and Screening of a cDNA Library Enriched for Gene
Sequences Preferentially Expressed by GC B Cells.
 
A library
of 8 
 
3
 
 10
 
5
 
 independent recombinant phage clones contain-
ing cDNA inserts averaging 1.2 kb was obtained from five
 
m
 
g of GC B lymphocyte polyA
 
1
 
 RNA. Two rounds of
hybridization of single-stranded DNA from the library with
a 100-fold excess of RNA isolated from the lymphoma
specimens, followed by removal of hybrids and conversion
of residual DNA strands to double-stranded plasmids, re-
duced the number of cDNAs in the library to 740.
To screen the 740 clones in the subtracted library for
cDNAs corresponding to genes upregulated in GCs, indi-
vidual cDNAs immobilized in triplicate on nylon mem-
branes were hybridized with labeled reverse transcription
products prepared from the RNA of tonsils and the two
lymphoma specimens used to construct the subtracted li-
brary. Those cDNAs that produced hybridization signals of
about equal intensity with three sets of probes were re-
garded as unlikely to represent genes specifically involved
in GC function and were therefore not further character-
ized. Those cDNAs that produced stronger signals with the
tonsil probes than with either lymphoma probe, as well as
cDNAs which gave uniformly weak signals with all probes
(and presumably represent rare transcripts), were tested sep-
arately as probes on Northern blots prepared with the
RNA of GC B cells and non-GC B cells isolated by mag-
netic beads separation, and with RNA from cells of various
other lymphoid, fetal nonlymphoid tissues and several es-
tablished B and T cell tumor lines.
Among the first 24 cDNAs used as probes, four showed
some specificity for RNA in GC B cells. One of these,
GCN5, detected two transcripts about 2.0 and 1.8 kb in
size predominantly in GC B cells and tonsil, but to a much
lesser extent in non-GC B cells, T cells, non–lymphoid hu-
man fetal tissues, or lymphoid tumor cell lines (Fig. 1,
bands 
 
A
 
 and 
 
B
 
). The larger of these transcripts (band 
 
B
 
) is
also present at low levels in the RNA from some of the
non–lymphoid tissues; however, the smaller transcript (band
 
A
 
) is almost undetectable anywhere other than in the RNA
of GC B cells and tonsil. Small amounts of a third tran- 
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script, 
 
z
 
2.3 kb in size (band 
 
C
 
), were also identified in
RNA of liver, lung, and brain using the GCN5 cDNA as a
probe.
 
Cloning and Structural Analysis of cDNAs Related to GCN5.
 
Since the size of the GCN5 cDNA in the plasmid clone
studied by us was 1.1 kb and the three transcripts identified
by Northern blot analysis were in the range of 2 kb, the
GCN5 cDNA appeared to fall short of a full-length copy of
any identifiable transcript. We therefore attempted to ob-
tain additional cDNAs containing upstream sequences from
the same transcript that gave rise to the GCN5 clone by us-
ing the 5
 
9
 
 end of the GCN5 cDNA to rescreen the unsub-
tracted GC B cell cDNA library. Several cDNAs were iso-
lated by this procedure, of which the longest cDNA was
termed GCN6. Sequence analysis of each cDNA found in-
dicated that, aside from GCN5 or 6, all others were partial
versions of these two.
The relationship between GCN5 and 6 is illustrated in
Fig. 2. Amplification by PCR of DNA from the unsub-
tracted GC B cell cDNA library using a 5
 
9
 
 primer comple-
mentary to sequence in the middle of GCN6 (Fig. 2, 
 
S4
 
)
and a 3
 
9
 
 primer complementary to sequence in the first part
of GCN5 (Fig. 2, 
 
A5
 
) yielded a fragment of the size and se-
quence expected from a continuous stretch of DNA (data
not shown). It therefore appears that GCN5 is an incom-
plete cDNA that shares a 5
 
9
 
 and coding sequence with
GCN6. However, GCN5 and 6 differ from each other in
exonic sequences at their 3
 
9
 
 ends, and consequently seem
to represent alternatively spliced transcripts of the same
gene. This interpretation was supported by the isolation of
genomic DNA fragments containing these sequences and
the finding within the genomic fragments of apparent in-
tronic sequences adjacent to the exons present in the two
cDNAs.
A probe containing sequence common to GCN5 and 6
(the region from 
 
S5
 
 to 
 
S
 
 plus 
 
S
 
 to 
 
A1
 
 in Fig. 2) detected all
three transcripts (
 
A–C
 
) identified in the Northern blot
(data not shown), whereas a probe specific to GCN5 (the
region between 
 
S2
 
 and 
 
A2
 
) detected only transcript C.
Furthermore, a 3
 
9
 
 GCN6-specific probe (the region be-
tween 
 
S6
 
 and 
 
A7
 
) detected both transcript A and B, but
not transcript C. We concluded that GCN5 corresponds to
transcript C and GCN6 to both transcripts A or B.
Efforts to determine the structural differences between
transcripts A and B were unsuccessful. A series of PCR
primers constructed from sequences within GCN6 were
Figure 1. Northern blot analysis of GCN6 and GCN5 expression. 10
mg of total RNA were loaded in each lane. (A) Autoradiogram of the blot
after hybridization with radiolabeled GCN5 cDNA. The three bands re-
ferred to in the text are labeled A, B, and C. (B) Photograph under ultra-
violet light of the agarose gel used in preparation of the Northern blot af-
ter staining of the gel with ethidium bromide to indicate the amount and
integrity of the RNA loaded on the gel.
Figure 2. Diagram of the
GCN5 and GCN6 cDNAs. The
labeled arrows above each cDNA
represent PCR primers used to
generate region-specific probes.
The two striped regions represent
coding exon in the calcium-cal-
modulin–dependent protein ki-
nase I transcript.1551 Kuo and Sklar
used to amplify fragments from the GC B cell cDNA li-
brary. Amplification with each pair of primers produced
only homogeneously sized fragments of lengths expected
from the sequence of GCN6. Also, probes prepared from
three different regions of the GCN6 (Fig. 2, S5-A3, S-A5,
and S6-A7) used on Northern blot analysis all hybridized to
the RNA of both bands A and B.
The GCN6 cDNA contains a 1,023-bp open reading
frame capable of encoding a protein having a molecular
weight of 37 kD. A BLAST homology search against a da-
tabase of known protein sequences revealed that the puta-
tive protein encoded by GCN6 has significant homology
to a recently reported yeast base excision DNA repair protein,
8-oxoguanine  DNA glycosylase (Ogg)1. Fig. 3 shows a
comparison of the GCN6 coding sequence and Ogg1. Sev-
eral regions of the two sequences are strongly homologous,
including one toward the COOH-terminal end of the
GCN6 open reading frame (codons 235–310), correspond-
ing to a part of Ogg1 proposed to contain the active site of
the enzyme. Within this region, the aspartic acid codon at
position 269 of the GCN6 sequence is conserved among
many of the DNA glycosylases and is thought to encode
the amino acid that acts as the nucleophile during the enzy-
matic reaction. For as far as it extends, the coding sequence
in GCN5 is identical to that in GCN6 before position 307
in the latter, after which GCN5 diverges completely and
continues for another 66 codons. Examination of this re-
gion of the sequence in the GCN5 cDNA did not reveal
significant homology to any protein in the database.
An unusual feature of both the GCN5 and 6 sequences is
the inclusion of short regions of inverted exonic sequence
from the calcium-calmodulin–dependent protein kinase I
gene (CCDPKI). This finding indicates that the GCN5/6
gene probably overlaps the CCDPKI gene in a reverse ori-
entation within the DNA. Probes containing several re-
gions of the GCN5 and 6 cDNAs hybridize to only a single
band in Southern blots of human genomic DNA digested
with a number of restriction enzymes (data not shown),
suggesting that the gene for GCN5/6 is located at the same
chromosomal site as CCDPKI, at band 3p25. The South-
ern blot results are also consistent with the conclusion that
GCN5 and 6 are derived from the same gene.
In Situ Hybridization Analysis of the Expression of GCN6
DNA in Tonsils. To analyze the distribution of expression
of GCN6 DNA in lymph node tissue, in situ hybridization
was performed with digoxigenin-labeled sense and anti-
sense riboprobes generated from the 39 end of GCN6
cDNA (Fig. 2, the region between S6 and A7). As seen in
Fig. 4, C and D, hybridization with a GCN6-specific anti-
sense probe was largely localized to the cells in the dark
zone of GCs present within sections of tonsil. Examination
under high magnification revealed that the cells showing
the strongest hybridization had a nuclear morphology com-
patible with centroblasts. Weaker hybridization was seen in
the light zone of GCs, but not in the B lymphocytes mak-
ing up the mantle zone. In some sections, scattered large
cells both outside the GC and between the light and dark
zone of the GC displayed intense hybridization. The nature
of these cells is not clear.
As a control, the sense GCN6 probe uniformly produced
only faint background hybridization in all regions of the
tonsil (Fig. 4 B). Also, hybridization specific for regions of
the tonsil other than GCs was obtained with probes for
certain cDNAs that emerged from the subtractive hybrid-
ization cloning scheme (Fig. 4, E and F).
Functional Analysis of the GST-GCN6 Fusion Protein. The yeast
Ogg1 protein has been shown to possess an 8-oxoguanine
DNA glycosylase activity (33). The glycosylase reaction
was demonstrated to proceed through a Schiff base inter-
mediate formed between the enzyme and the DNA at the
site of the modified guanine. Furthermore, this intermedi-
ate could be trapped by addition of sodium borohydride
(NaBH4) to the reaction (34). Given these properties of the
yeast enzyme, we tested the ability of the protein encoded
by the GCN6 cDNA to form in vitro the same intermedi-
ate as the yeast enzyme. A cDNA fusion construct contain-
ing all but the first 11 codons of the GCN6 coding se-
quence fused to sequence encoding GST was expressed in a
strain of E. coli mutant for MutM (MC301), the gene for
Figure 3. Comparison of amino acid sequences of GCN5, GCN6, and
yeast Ogg1 (YOGGI). The alignment was performed by the Bestfit pro-
gram in the Wisconsin GCG package. Identical amino acids are marked
by a vertical line between amino acids in the respective sequences and
conserved changes by a colon. Dots represent gaps in the sequence gener-
ated by the program to allow better alignment. The overall identity is cal-
culated to be 37%. The GCN5 is a partial cDNA that begins at codon 215
in GCN6. The aspartic acid conserved in the presumed active site among
DNA glycosylases is underlined. The DNA sequences reported in the pa-
per are available from EMBL/Genbank/DDBJ under accession number
AF 026691.1552 Human MutM in Germinal Centers of Lymph Nodes
8-oxoguanine DNA glycosylase in bacteria. Purified GST-
GCN6 fusion protein was then incubated under a variety
of conditions with end-labeled, double-stranded oligonu-
cleotides with or without an oxidized guanine in one or
the other strand at the center of the sequence. As shown in
Fig. 5 A, a band representing a covalently linked protein–
DNA complex was found only when oxidized guanine was
included in the oligonucleotide substrate (Fig. 5 A, lanes 5
and 6) and only in the presence of NaBH4 (Fig. 5 A, lanes
3 and 4). The control GST protein alone produced no
complex (Fig. 5 A, lanes 1 and 2). Additionally, the GST-
GCN6 fusion protein caused nicking of the oligonucle-
otides at the position of the oxidized guanine in a manner
similar to that observed with the yeast protein (Fig. 5 B).
Discussion
Our decision to use subtractive hybridization for the iden-
tification of genes involved in B lymphocyte functions
within GCs was based on several key considerations. Many
Figure 4. In situ hybridization on paraffin-embedded formalin-fixed sections of human tonsils. (A) A hematoxylin and eosin–stained section showing
the dark (DZ), light (LZ), and mantle (MZ) zones of a GC. (B–D) Sections hybridized with GCN6 cDNA into which digoxigenin nucleotides have been
incorporated, followed by detection with antidigoxigenin antibody conjugated to alkaline phosphatase and identification of the locations of bound anti-
body by deposition of dark blue phosphatase reaction product. The nuclei were counterstained with methyl green. (B) Sense strand probe of GCN6. (C
and D) Antisense probe of GCN6. (E and F) Antisense probe of GCN7, a cDNA derived from a gene apparently expressed primarily in mantle cells.
Original magnification was 40 for B, D, and F and 100 for A, C, and E.1553 Kuo and Sklar
events essential to the normal humoral immune response
occur within the GC, but relatively little is known about
the molecular mechanisms or genes controlling these
events. Although subtractive hybridization of non-GC
transcripts from GC transcripts would not define a set of
RNAs with discrete functions, we felt that any RNA that
we could demonstrate was derived from a gene that
showed significantly increased expression in GCs would
likely be relevant to one or the other important process
within these highly active structures. Although a priori, we
had no simple assay to test for any specific function of genes
we might identify through construction of a subtractive
GC cDNA library, we believed we could probably infer
functional information by searching for sequence homolo-
gies between a cDNA within the library and entries within
the ever-expanding databases of gene sequences from vari-
ous organisms. We chose a cloning strategy involving sub-
tractive hybridization over competing techniques, such as a
candidate gene approach (35) or differential display (36),
because we wished to survey both known and previously
undiscovered genes and because we did not want to ex-
clude from our study genes expressed as low abundance
transcripts, which may happen more easily using methods
that rely on PCR.
A major factor in any successful application of subtractive
hybridization to cloning of cDNAs is the quality of the
positive and negative starting materials. The positive start-
ing material in our study, B lymphocytes isolated from the
GCs of tonsils by antigenic selection, provided small but
adequate amounts of RNA to begin the procedure. How-
ever, these isolated populations of B lymphocytes were not
pure, as indicated by flow cytometric analysis of the cells,
the difficulty in quantitating gene expression in slot blots
prepared with RNA from the isolated cell populations, and
the inclusion in the subtracted library of cDNA clones rep-
resenting genes expressed in regions of the lymph node
outside the GC (for example, in the mantle zone; see Fig.
4, E and F). The impurity of the GC B lymphocytes prob-
ably also accounts in part for the unexpectedly large size of
the subtractive library we obtained.
Pooled lymph nodes containing non–Hodgkin’s lym-
phomas were used as the source of negative cells because
the two subtypes of lymphomas present in these specimens
are known to be composed of neoplastic B lymphocytes
that do not undergo somatic hypermutation or switch re-
combination (37–39). More generally, B lymphocytes in
the two subtypes of lymphoma mimic the stages of normal
B cell development preceding passage through the GC and
might therefore be more likely to express genes involved in
a range of B cell functions exclusive of those that take place
only in the GC. Furthermore, the large amounts of fresh
lymphoma tissue available to us provided a convenient sup-
ply of relatively homogeneous, non-GC B lymphocytes for
the preparation of the abundant amounts of RNA required
in the subtraction step. Finally, the cells within these tu-
mors are actively dividing, and accordingly, subtraction
with RNA extracted from them might be anticipated to
remove cDNA clones related only to cell proliferation per
se. On the other hand, the tissues containing the two lym-
phomas are undoubtedly contaminated by nonmalignant B
lymphocytes, some of which may have been present in re-
sidual GCs. Consequently, it is possible that cDNAs for
some rare GC transcripts may have been eliminated from
the library by subtraction with RNA from these lymphoma
specimens.
Despite all the potential theoretical and practical prob-
lems associated with subtractive hybridization, the ultimate
justification for the strategy we pursued is the finding
within our library of cDNAs that clearly correspond to
genes upregulated within GCs. In this report, we have de-
scribed in detail two such cDNAs, GCN6 and GCN5,
which originate from a gene that is over-expressed in GC
B lymphocytes relative to other cells and tissues. The two
cDNAs apparently represent alternatively spliced transcripts
of the same gene, but only the sequences contained within
GCN6 are present at increased levels in the RNA of GC B
lymphocytes by blot or in situ hybridization. Hybridization
of Northern blots with probes from the GCN6 sequence
detected, in turn, two transcripts, A and B. The structural
differences between these two transcripts is not apparent
based on any of the analyses performed by us, but the
shorter transcript (A) is virtually limited to GC B lympho-
cytes in our investigations so far, although the level of the
longer transcript B is increased in GC B lymphocytes as
well.
Our analyses indicate that the polypeptide encoded by
the GCN6 cDNA is both structurally and functionally ho-
mologous to Oggs found in lower organisms. In E. coli, this
enzyme, encoded by the MutM gene, together with the
products of MutY and MutT, comprise the GO repair sys-
Figure 5. Functional assays of the GST-GCN6 fusion protein. (A)
Trapping of the Schiff base intermediate by the addition of sodium boro-
hydride. Double-stranded, 39 end–labeled oligonucleotides either with
(oG:C, lanes 1–4) or without (G:C, lanes 5 and 6) an 8-oxoguanine at the
center of the fragment were incubated with either with GST alone (lanes
1 and 2) or GST-GCN6 fusion protein (lanes 3–6) in the presence (lanes
2, 4, and 6) or absence (lanes 1, 3, and 5) of sodium borohydride. The re-
action products were analyzed by 8% SDS-PAGE gel electrophoresis fol-
lowed by autoradiography. The presence of a protein–DNA conjugate
can be detected as a slow mobility band indicated by the arrow. (B)
Cleavage of double-stranded oligonucleotides containing 8-oxoguanine.
Double-stranded, 39 end–labeled oligonucleotides with or without an
8-oxoguanine were incubated with GST alone (lanes 1 and 5) or GST-
GCN6 fusion protein (lanes 3 and 6), and the reaction products analyzed
by electrophoresis in a 12% polyacrylamide-7M urea gel followed by au-
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tem (40), which protects against the mutagenic effects of
oxidatively damaged guanosine nucleotides. The human
homologues of the MutY and MutT genes, and their pro-
tein products have been identified and characterized bio-
chemically (41–44). Both perform functions similar to their
bacterial counterparts (MutY: excision of adenine incorpo-
rated opposite 8-oxoguanine; MutT: removal of 8-oxo-dGTP
from the deoxynucleoside triphosphate pool). Enzymatic
activity similar to that of MutM in E. coli has also been
identified in Hela cell extracts (45, 46). The ability of the
polypeptide encoded by GCN6 to bind in vitro to oligo-
nucleotides containing 8-oxoguanine and cause nicking of
DNA at this site is compatible with the properties of both
the E. coli enzyme and the activity in Hela cell extracts.
Oxidation of guanine has been proposed to be the most
important lesion of DNA leading to spontaneous mutations
seen in somatic cells (47–49). The almost certain require-
ment by all cells for a means to repair this lesion probably
explains the low amounts of GCN6 transcripts B and C
found in most tissues. The abundance of transcript B and
the appearance of large amounts of the distinct transcript A
in tissues containing GCs would seem to imply some spe-
cial function or need for Ogg at these sites. The high con-
centration of GCN6 RNA in the dark zone of the GC, as
demonstrated by in situ hybridization, suggests that the rea-
son for changes in expression of the GCN5/6 gene relate
to processes specifically associated with this region of the
GC. The two most plausible candidates for these processes
are cell proliferation and somatic hypermutation, although,
of course, other processes yet to be described in the dark
zone could also account for the upregulation of this gene.
Since GCN5/6 transcripts were not detected in increased
numbers either in rapidly dividing cells of fetal tissues or
lymphoid tumor cell lines (Fig. 1), altered expression of the
GCN5/6 gene probably does not serve a role connected
solely to proliferation. Therefore, based only on those pro-
cesses known to occur within the dark zone of the GC, we
surmise that the GCN5/6 gene is most likely somehow in-
volved in somatic hypermutation.
In view of the function of Ogg in DNA repair, the in-
creased expression of the GCN5/6 gene at a site of en-
hanced mutation initially seems paradoxical. A variety of
explanations for this paradox is possible, but the most co-
gent one may be the following. Oxidative damage to DNA
within cells of the dark zone of the GC occurs at an unusu-
ally high rate, due perhaps in part to large amounts of reac-
tive oxygen free radicals released from macrophages during
the phagocytosis of cell debris generated by the exuberant
apoptosis that takes place in the GC. This damage affects
the entire genome, requiring increased levels of Ogg. At
the same time, the V segments of rearranged immunoglob-
ulin genes within B cells of the dark zone are protected
from repair, possibly by a protein that shields DNA at these
loci from Ogg action. In this regard, it may be noteworthy
that in one B cell line reported to show some degree of so-
matic hypermutation, the base substitutions affect G:C
more frequently than other basepairs within the immuno-
globulin DNA (50). Furthermore, experiments have indi-
cated that after treatment with ultraviolet light, the DNA
of rearranged V gene segments in GC B cells are repaired
less efficiently than other regions of immunoglobulin genes
or similar segments of non-GC B cells (51). In any case,
besides conforming with observations previously reported
on somatic hypermutation (8, 52, 53), the above model
makes a number of specific predictions which should be
testable in the near future.
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